89
Digital therapeutic and digital biomarker platform for severe mental illnesses related to schizophrenia, psychosis and opioid use disorder.
AMOS ADLER CEO A4i Inc.
DR. SEAN KIDD CSO A4i Inc.
Presented by:
2023 ANNUAL REPORT ON ANGEL INVESTING IN CANADA
Powered by FlippingBook